Secondary causes for low BMD common

Article

Many postmenopausal breast cancer survivors may have secondary causes of low bone mineral density that are potentially treatable, according to research published online on June 22 in the Journal of Clinical Oncology.

Many postmenopausal breast cancer survivors may have secondary causes of low bone mineral density that are potentially treatable, according to research published online on June 22 in the Journal of Clinical Oncology.

G. Bruce Mann, PhD, of the Royal Women’s Hospital in Victoria, Australia, and colleagues analyzed data from 200 women--median age at diagnosis, 62 years-who’d been diagnosed with breast cancer within the previous 5 years. Subjects’ bone mineral density (BMD) was checked, and blood samples were tested for serum calcium, vitamin D, thyroid function, and parathyroid hormone.

The researchers found that roughly 47% of the women had osteopenia and 12.8% had osteoporosis. Many had insufficient (37%) or deficient (27%) vitamin D, and 21% had higher than normal parathyroid hormone concentrations. Six women had primary hyperparathyroidism (PHPT) and two had recent surgery for the condition, while 27 had secondary hyperparathyroidism from vitamin D deficiency and six had normocalcemic hyperparathyroidism. Of the patients with low BMD and hormone receptor-positive cancer, the authors note that 8% had recent or new PHPT.

“Secondary causes of osteoporosis should be sought and corrected, particularly in patients with hormone receptor-positive breast cancer and low BMD. Vitamin D should be measured and supplemented if low; repeat testing is appropriate to confirm adequate vitamin D replacement. Calcium levels should be checked, PHPT should be specifically sought if calcium levels are high, and PHPT should be treated appropriately,” the authors conclude.

Two co-authors reported financial associations with Novartis Pharmaceuticals.

Mann GB, Kang YC, Brand C, et al. Secondary causes of low bone mass in patients with breast cancer: A need for greater vigilance. J Clin Oncol. 2009 Jun 22 [Epub ahead of print]; doi: 10.1200/JCO.2008.20.2549.

Recent Videos
Mirvie's RNA platform revolutionizes detection of fetal growth restriction | Image Credit: wexnermedical.osu.edu
How early genetic testing empowers parents and improves outcomes | Image Credit: tuftsmedicine.org
Dallas Reed highlights trends and barriers in prenatal genetic testing | Image Credit: tuftsmedicine.org
How maternal fetal medicine specialists improve outcomes for high-risk pregnancies | Image Credit: profiles.mountsinai.org
How the cobas liat assay panels improve STI detection | Image Credit: labqualityconfab.
Screening-to-diagnosis interval vital for gestational diabetes outcomes | Image Credit: ultracon2024.eventscribe.net
Henri M. Rosenberg, MD
Medical experts personalize contraceptive options for complex cases | Image Credit: findcare.ahn.org
Study explores the limits of neighborhood data in predicting preterm birth | Image Credit: linkedin.com
Barbed suture reduces blood loss in hysterectomy | Image Credit: linkedin.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.